[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Neisseria meningitidis Infections Drug Market Report 2018

January 2018 | 115 pages | ID: A7B10432A7BEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Neisseria meningitidis Infections Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Neisseria meningitidis Infections Drug for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Neisseria meningitidis Infections Drug market competition by top manufacturers/players, with Neisseria meningitidis Infections Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Beijing Minhai Biotechnology Co Ltd
  • Biological E Ltd
  • China National Pharmaceutical Group Corp
  • GlaxoSmithKline Plc
  • Griffith University
  • ImmunoBiology Ltd
  • JN-International Medical Corp
  • MGB Biopharma Ltd
  • Panacea Biotec Ltd
  • Pfizer Inc
  • Sanofi Pasteur SA
  • Serum Institute of India Ltd
  • Wellstat Vaccines LLC
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • MGBBP-3
  • NCL-195
  • TP-10
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Clinic
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Neisseria meningitidis Infections Drug Market Report 2017

1 NEISSERIA MENINGITIDIS INFECTIONS DRUG OVERVIEW

1.1 Product Overview and Scope of Neisseria meningitidis Infections Drug
1.2 Classification of Neisseria meningitidis Infections Drug by Product Category
  1.2.1 Asia-Pacific Neisseria meningitidis Infections Drug Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Neisseria meningitidis Infections Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 MGBBP-3
  1.2.4 NCL-195
  1.2.5 TP-10
  1.2.6 Others
1.3 Asia-Pacific Neisseria meningitidis Infections Drug Market by Application/End Users
  1.3.1 Asia-Pacific Neisseria meningitidis Infections Drug Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 Asia-Pacific Neisseria meningitidis Infections Drug Market by Region
  1.4.1 Asia-Pacific Neisseria meningitidis Infections Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Neisseria meningitidis Infections Drug (2012-2022)
  1.5.1 Asia-Pacific Neisseria meningitidis Infections Drug Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Neisseria meningitidis Infections Drug Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC NEISSERIA MENINGITIDIS INFECTIONS DRUG COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Neisseria meningitidis Infections Drug Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Neisseria meningitidis Infections Drug Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Neisseria meningitidis Infections Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Neisseria meningitidis Infections Drug (Volume and Value) by Type
  2.2.1 Asia-Pacific Neisseria meningitidis Infections Drug Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Neisseria meningitidis Infections Drug Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Neisseria meningitidis Infections Drug (Volume) by Application
2.4 Asia-Pacific Neisseria meningitidis Infections Drug (Volume and Value) by Region
  2.4.1 Asia-Pacific Neisseria meningitidis Infections Drug Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Neisseria meningitidis Infections Drug Revenue and Market Share by Region (2012-2017)

3 CHINA NEISSERIA MENINGITIDIS INFECTIONS DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 China Neisseria meningitidis Infections Drug Sales and Value (2012-2017)
  3.1.1 China Neisseria meningitidis Infections Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Neisseria meningitidis Infections Drug Revenue and Growth Rate (2012-2017)
  3.1.3 China Neisseria meningitidis Infections Drug Sales Price Trend (2012-2017)
3.2 China Neisseria meningitidis Infections Drug Sales Volume and Market Share by Type
3.3 China Neisseria meningitidis Infections Drug Sales Volume and Market Share by Application

4 JAPAN NEISSERIA MENINGITIDIS INFECTIONS DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Neisseria meningitidis Infections Drug Sales and Value (2012-2017)
  4.1.1 Japan Neisseria meningitidis Infections Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Neisseria meningitidis Infections Drug Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Neisseria meningitidis Infections Drug Sales Price Trend (2012-2017)
4.2 Japan Neisseria meningitidis Infections Drug Sales Volume and Market Share by Type
4.3 Japan Neisseria meningitidis Infections Drug Sales Volume and Market Share by Application

5 SOUTH KOREA NEISSERIA MENINGITIDIS INFECTIONS DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Neisseria meningitidis Infections Drug Sales and Value (2012-2017)
  5.1.1 South Korea Neisseria meningitidis Infections Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Neisseria meningitidis Infections Drug Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Neisseria meningitidis Infections Drug Sales Price Trend (2012-2017)
5.2 South Korea Neisseria meningitidis Infections Drug Sales Volume and Market Share by Type
5.3 South Korea Neisseria meningitidis Infections Drug Sales Volume and Market Share by Application

6 TAIWAN NEISSERIA MENINGITIDIS INFECTIONS DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Neisseria meningitidis Infections Drug Sales and Value (2012-2017)
  6.1.1 Taiwan Neisseria meningitidis Infections Drug Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Neisseria meningitidis Infections Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Neisseria meningitidis Infections Drug Sales Price Trend (2012-2017)
6.2 Taiwan Neisseria meningitidis Infections Drug Sales Volume and Market Share by Type
6.3 Taiwan Neisseria meningitidis Infections Drug Sales Volume and Market Share by Application

7 INDIA NEISSERIA MENINGITIDIS INFECTIONS DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 India Neisseria meningitidis Infections Drug Sales and Value (2012-2017)
  7.1.1 India Neisseria meningitidis Infections Drug Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Neisseria meningitidis Infections Drug Revenue and Growth Rate (2012-2017)
  7.1.3 India Neisseria meningitidis Infections Drug Sales Price Trend (2012-2017)
7.2 India Neisseria meningitidis Infections Drug Sales Volume and Market Share by Type
7.3 India Neisseria meningitidis Infections Drug Sales Volume and Market Share by Application

8 SOUTHEAST ASIA NEISSERIA MENINGITIDIS INFECTIONS DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Neisseria meningitidis Infections Drug Sales and Value (2012-2017)
  8.1.1 Southeast Asia Neisseria meningitidis Infections Drug Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Neisseria meningitidis Infections Drug Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Neisseria meningitidis Infections Drug Sales Price Trend (2012-2017)
8.2 Southeast Asia Neisseria meningitidis Infections Drug Sales Volume and Market Share by Type
8.3 Southeast Asia Neisseria meningitidis Infections Drug Sales Volume and Market Share by Application

9 AUSTRALIA NEISSERIA MENINGITIDIS INFECTIONS DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Neisseria meningitidis Infections Drug Sales and Value (2012-2017)
  9.1.1 Australia Neisseria meningitidis Infections Drug Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Neisseria meningitidis Infections Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Neisseria meningitidis Infections Drug Sales Price Trend (2012-2017)
9.2 Australia Neisseria meningitidis Infections Drug Sales Volume and Market Share by Type
9.3 Australia Neisseria meningitidis Infections Drug Sales Volume and Market Share by Application

10 ASIA-PACIFIC NEISSERIA MENINGITIDIS INFECTIONS DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Beijing Minhai Biotechnology Co Ltd
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Neisseria meningitidis Infections Drug Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Biological E Ltd
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Neisseria meningitidis Infections Drug Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Biological E Ltd Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 China National Pharmaceutical Group Corp
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Neisseria meningitidis Infections Drug Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 GlaxoSmithKline Plc
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Neisseria meningitidis Infections Drug Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Griffith University
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Neisseria meningitidis Infections Drug Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Griffith University Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 ImmunoBiology Ltd
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Neisseria meningitidis Infections Drug Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 JN-International Medical Corp
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Neisseria meningitidis Infections Drug Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 JN-International Medical Corp Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 MGB Biopharma Ltd
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Neisseria meningitidis Infections Drug Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Panacea Biotec Ltd
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Neisseria meningitidis Infections Drug Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Pfizer Inc
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Neisseria meningitidis Infections Drug Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Pfizer Inc Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Sanofi Pasteur SA
10.12 Serum Institute of India Ltd
10.13 Wellstat Vaccines LLC

11 NEISSERIA MENINGITIDIS INFECTIONS DRUG MANUFACTURING COST ANALYSIS

11.1 Neisseria meningitidis Infections Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Neisseria meningitidis Infections Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Neisseria meningitidis Infections Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Neisseria meningitidis Infections Drug Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Neisseria meningitidis Infections Drug Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Neisseria meningitidis Infections Drug Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Neisseria meningitidis Infections Drug Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Neisseria meningitidis Infections Drug Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Neisseria meningitidis Infections Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Neisseria meningitidis Infections Drug Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Neisseria meningitidis Infections Drug Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Neisseria meningitidis Infections Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Neisseria meningitidis Infections Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Neisseria meningitidis Infections Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Neisseria meningitidis Infections Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Neisseria meningitidis Infections Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Neisseria meningitidis Infections Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Neisseria meningitidis Infections Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Neisseria meningitidis Infections Drug Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Neisseria meningitidis Infections Drug Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Neisseria meningitidis Infections Drug Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Neisseria meningitidis Infections Drug Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Neisseria meningitidis Infections Drug Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Neisseria meningitidis Infections Drug
Figure Asia-Pacific Neisseria meningitidis Infections Drug Sales Volume (K Pcs) by Type (2012-2022)
Figure Asia-Pacific Neisseria meningitidis Infections Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure MGBBP-3 Product Picture
Figure NCL-195 Product Picture
Figure TP-10 Product Picture
Figure Others Product Picture
Figure Asia-Pacific Neisseria meningitidis Infections Drug Sales (K Pcs) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Neisseria meningitidis Infections Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Neisseria meningitidis Infections Drug Market Size (Million USD) by Region (2012-2022)
Figure China Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Neisseria meningitidis Infections Drug Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Asia-Pacific Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Neisseria meningitidis Infections Drug Market Major Players Product Sales Volume (K Pcs)(2012-2017)
Table Asia-Pacific Neisseria meningitidis Infections Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Neisseria meningitidis Infections Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Neisseria meningitidis Infections Drug Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Neisseria meningitidis Infections Drug Sales Share by Players/Suppliers
Figure Asia-Pacific Neisseria meningitidis Infections Drug Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Neisseria meningitidis Infections Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Neisseria meningitidis Infections Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Neisseria meningitidis Infections Drug Revenue Share by Players
Figure 2017 Asia-Pacific Neisseria meningitidis Infections Drug Revenue Share by Players
Table Asia-Pacific Neisseria meningitidis Infections Drug Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Neisseria meningitidis Infections Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Neisseria meningitidis Infections Drug by Type (2012-2017)
Figure Asia-Pacific Neisseria meningitidis Infections Drug Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Neisseria meningitidis Infections Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Neisseria meningitidis Infections Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Neisseria meningitidis Infections Drug by Type (2012-2017)
Figure Asia-Pacific Neisseria meningitidis Infections Drug Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Neisseria meningitidis Infections Drug Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Asia-Pacific Neisseria meningitidis Infections Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Neisseria meningitidis Infections Drug by Region (2012-2017)
Figure Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share by Region in 2016
Table Asia-Pacific Neisseria meningitidis Infections Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Neisseria meningitidis Infections Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Neisseria meningitidis Infections Drug by Region (2012-2017)
Figure Asia-Pacific Neisseria meningitidis Infections Drug Revenue Market Share by Region in 2016
Table Asia-Pacific Neisseria meningitidis Infections Drug Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Asia-Pacific Neisseria meningitidis Infections Drug Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share by Application (2012-2017)
Figure China Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Neisseria meningitidis Infections Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table China Neisseria meningitidis Infections Drug Sales Volume (K Pcs) by Type (2012-2017)
Table China Neisseria meningitidis Infections Drug Sales Volume Market Share by Type (2012-2017)
Figure China Neisseria meningitidis Infections Drug Sales Volume Market Share by Type in 2016
Table China Neisseria meningitidis Infections Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table China Neisseria meningitidis Infections Drug Sales Volume Market Share by Application (2012-2017)
Figure China Neisseria meningitidis Infections Drug Sales Volume Market Share by Application in 2016
Figure Japan Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Neisseria meningitidis Infections Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Neisseria meningitidis Infections Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Neisseria meningitidis Infections Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Neisseria meningitidis Infections Drug Sales Volume Market Share by Type in 2016
Table Japan Neisseria meningitidis Infections Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Japan Neisseria meningitidis Infections Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Neisseria meningitidis Infections Drug Sales Volume Market Share by Application in 2016
Figure South Korea Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure South Korea Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Neisseria meningitidis Infections Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table South Korea Neisseria meningitidis Infections Drug Sales Volume (K Pcs) by Type (2012-2017)
Table South Korea Neisseria meningitidis Infections Drug Sales Volume Market Share by Type (2012-2017)
Figure South Korea Neisseria meningitidis Infections Drug Sales Volume Market Share by Type in 2016
Table South Korea Neisseria meningitidis Infections Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table South Korea Neisseria meningitidis Infections Drug Sales Volume Market Share by Application (2012-2017)
Figure South Korea Neisseria meningitidis Infections Drug Sales Volume Market Share by Application in 2016
Figure Taiwan Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Taiwan Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Neisseria meningitidis Infections Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Taiwan Neisseria meningitidis Infections Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Taiwan Neisseria meningitidis Infections Drug Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Neisseria meningitidis Infections Drug Sales Volume Market Share by Type in 2016
Table Taiwan Neisseria meningitidis Infections Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Taiwan Neisseria meningitidis Infections Drug Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Neisseria meningitidis Infections Drug Sales Volume Market Share by Application in 2016
Figure India Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Neisseria meningitidis Infections Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table India Neisseria meningitidis Infections Drug Sales Volume (K Pcs) by Type (2012-2017)
Table India Neisseria meningitidis Infections Drug Sales Volume Market Share by Type (2012-2017)
Figure India Neisseria meningitidis Infections Drug Sales Volume Market Share by Type in 2016
Table India Neisseria meningitidis Infections Drug Sales Volume (K Pcs) by Application (2012-2017)
Table India Neisseria meningitidis Infections Drug Sales Volume Market Share by Application (2012-2017)
Figure India Neisseria meningitidis Infections Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Neisseria meningitidis Infections Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Neisseria meningitidis Infections Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Neisseria meningitidis Infections Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Neisseria meningitidis Infections Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Neisseria meningitidis Infections Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Southeast Asia Neisseria meningitidis Infections Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Neisseria meningitidis Infections Drug Sales Volume Market Share by Application in 2016
Figure Australia Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Australia Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Neisseria meningitidis Infections Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Australia Neisseria meningitidis Infections Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Australia Neisseria meningitidis Infections Drug Sales Volume Market Share by Type (2012-2017)
Figure Australia Neisseria meningitidis Infections Drug Sales Volume Market Share by Type in 2016
Table Australia Neisseria meningitidis Infections Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Australia Neisseria meningitidis Infections Drug Sales Volume Market Share by Application (2012-2017)
Figure Australia Neisseria meningitidis Infections Drug Sales Volume Market Share by Application in 2016
Table Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Basic Information List
Table Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Biological E Ltd Neisseria meningitidis Infections Drug Basic Information List
Table Biological E Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biological E Ltd Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Biological E Ltd Neisseria meningitidis Infections Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Biological E Ltd Neisseria meningitidis Infections Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Basic Information List
Table China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Basic Information List
Table GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Griffith University Neisseria meningitidis Infections Drug Basic Information List
Table Griffith University Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Griffith University Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Griffith University Neisseria meningitidis Infections Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Griffith University Neisseria meningitidis Infections Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table ImmunoBiology Ltd Neisseria meningitidis Infections Drug Basic Information List
Table ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure ImmunoBiology Ltd Neisseria meningitidis Infections Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table JN-International Medical Corp Neisseria meningitidis Infections Drug Basic Information List
Table JN-International Medical Corp Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure JN-International Medical Corp Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure JN-International Medical Corp Neisseria meningitidis Infections Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure JN-International Medical Corp Neisseria meningitidis Infections Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table MGB Biopharma Ltd Neisseria meningitidis Infections Drug Basic Information List
Table MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure MGB Biopharma Ltd Neisseria meningitidis Infections Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Panacea Biotec Ltd Neisseria meningitidis Infections Drug Basic Information List
Table Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Panacea Biotec Ltd Neisseria meningitidis Infections Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Pfizer Inc Neisseria meningitidis Infections Drug Basic Information List
Table Pfizer Inc Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Inc Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Inc Neisseria meningitidis Infections Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer Inc Neisseria meningitidis Infections Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Sanofi Pasteur SA Neisseria meningitidis Infections Drug Basic Information List
Table Serum Institute of India Ltd Neisseria meningitidis Infections Drug Basic Information List
Table Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Pcs) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neisseria meningitidis Infections Drug
Figure Manufacturing Process Analysis of Neisseria meningitidis Infections Drug
Figure Neisseria meningitidis Infections Drug Industrial Chain Analysis
Table Raw Materials Sources of Neisseria meningitidis Infections Drug Major Manufacturers in 2016
Table Major Buyers of Neisseria meningitidis Infections Drug
Table Distributors/Traders List
Figure Asia-Pacific Neisseria meningitidis Infections Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Neisseria meningitidis Infections Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Asia-Pacific Neisseria meningitidis Infections Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)
Figure Asia-Pacific Neisseria meningitidis Infections Drug Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Neisseria meningitidis Infections Drug Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Neisseria meningitidis Infections Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Neisseria meningitidis Infections Drug Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Neisseria meningitidis Infections Drug Revenue Market Share Forecast by Region in 2022
Figure China Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure South Korea Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Taiwan Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Australia Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Neisseria meningitidis Infections Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Neisseria meningitidis Infections Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Neisseria meningitidis Infections Drug Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Neisseria meningitidis Infections Drug Price (USD/Pcs) Forecast by Type (2017-2022)
Table Asia-Pacific Neisseria meningitidis Infections Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories